David Holtgrave, Ph.D. is a Professor in the Department of Behavioral Sciences and Health Education at the Rollins School of Public Health of Emory University, and the Director of the Behavioral and Social Sciences Core in the Emory Center for AIDS Research. Dr. Holtgrave's interests include cost-effectiveness analysis methods and applications, HIV prevention intervention research, and the uses of prevention science in public health policy making. He formerly served as Director of the Division of HIV/AIDS Prevention – Intervention Research and Support at the CDC. He received his Ph.D. from the University of Illinois in 1988, and was a member of the Wisconsin HIV Prevention Community Planning Council from 1996-7.

David R. Nerenz, Ph.D. is Director of the Institute for Health Care Studies and Professor in the College of Human Medicine at Michigan State University. His former positions include Director of the Center for Health System Studies at the Henry Ford Health System, Assistant Research Scientist and Lecturer in the University of Michigan School of Public Health, and Chief of the Great Lakes Regional Health Services Research & Development Field Program at the Ann Arbor VA Medical Center. He has conducted research and published articles on measuring effectiveness of health care systems, outcomes analysis, quality of care measurement, and racial/ethnic disparities in quality of care. He previously served on the IOM Committee on Measuring the Health of Gulf War Veterans and the IOM Committee on Effective Treatments for Gulf War Veterans. Dr. Nerenz received his Ph.D. in Social Psychology from the University of Wisconsin-Madison with minors in Statistics and Mathematics.

Dr. David Vlahov, Ph.D. is Director for the Center for Urban Epidemiologic Studies at the New York Academy of Medicine and Adjunct Professor of Public Health at the Joseph L. Mailman School of Public Health at Columbia University, with an adjunct appointment in Epidemiology at the Johns Hopkins School of Public Health. Dr. Vlahov completed his BSN and MS in Nursing at the University of Maryland and a Ph.D. in epidemiology at Johns Hopkins School of Public Health. He has developed extensive experience in the design, conduct, and analysis of infectious disease epidemiological studies. He has been Principal Investigator of the Natural History of HIV Infection among Injection Drug Users (the ALIVE Study). Key collaborations have included joint investigations with the Multi-center AIDS Cohort Study, and internationally with cohort studies in Italy, France and the Netherlands. For this study, funded by the National Institute on Drug Abuse, the NIH recognized Dr. Vlahov with the MERIT Award. Dr. Vlahov was also a Principal Investigator of the CDC funded HERS study to investigate gender specific factors associated with HIV progression in women. In addition, Dr. Vlahov has been involved with the evaluation of HIV prevention activities including the Needle Exchange Programs in Washington, D.C. and Baltimore, Maryland. Dr. Vlahov has over 300 publications in peer-reviewed journals. Dr. Vlahov has been the primary advisor for twenty doctoral and post-doctoral students. He is the editor-in-chief of the Journal of Urban Health: Bulletin of the New York Academy of Medicine.

James G. Kahn, M.D., M.P.H. is an Associate Professor at the University of California, San Francisco, in the Institute for Health Policy Studies, the Department of Epidemiology and Biostatistics, and the AIDS Research Institute. His major research interests are the HIV/AIDS treatment costs and the cost-effectiveness of prevention and treatment, health care financing and reform, and international health. Dr. Kahn recently studied racial disparities in access to antiretroviral therapy in Medicaid and ADAP in four states; the health and financial implications of expanding national Medicaid to cover individuals with HIV; and techniques to measure unmet need for HIV primary care. Dr. Kahn received his M.D. at Albert Einstein College of Medicine and his MPH in Epidemiology from the University of California, Berkeley.

Julie Sochalski, Ph.D., FAAN, RN is an Associate Professor at the University of Pennsylvania School of Nursing, and Research Faculty in the Center for Health Outcomes and Policy Research at the School of Nursing. Dr. Sochalski is also a Senior Fellow at the Leonard Davis Institute of Health Economics at the University of Pennsylvania and Research Associate in the Population Studies Center. She has held senior policy analyst positions at the United Hospital Fund of New York and the Prospective Payment Assessment Commission in Washington, D.C., and served on the Board of Directors of Blue Cross and Blue Shield of Michigan. She was a 1992-1993 Robert Wood Johnson Health Policy Fellow. Her research portfolio includes federally-funded and foundation-supported studies in the quality and outcomes of hospital care in the U.S., Canada, the U.K. and Germany; the impact of geriatric rehabilitation for frail elders on functional status and health service use; and trends in the national and international nursing workforce.

Mark Barnes, J.D., LL.M. is a partner in the health care practice of Ropes & Gray's New York Office, where he represents hospitals, health care associations, physicians, social services agencies, and related organizations in regulatory, reimbursement, research, HIPAA compliance, and litigation matters. Mr. Barnes serves as a member of the National Human Research Protections Advisory Committee of the United States Office of Human Research Protections, and a board member of Doctors of the World. His recent articles on HIPAA compliance and conflicts of interest in human research have appeared in BNA Health Law Reporter. Mark served as the Director of Policy for the New York State Department of Health AIDS Institute in the early 1990s. In 1993, he was a consultant to the White House National Health Care Reform Task Force, and he served from 1992 to 1994 as Associate Commissioner for Medical and Legal Policy for the New York City Department of Health. In the mid 1990s, Mark was the Executive Director of the AIDS Action Council, where he lobbied and advocated on AIDS funding and policy before Congress, federal agencies, and the Office of the President. Educated at Yale Law School and Columbia University School of Law, Mark taught full time at Columbia for four years, and more recently has served as an Adjunct Professor of Law at a number of law schools, including Brooklyn Law School and New York University School of Law.

Paul Volberding, M.D. is a Professor and Vice-Chair in the Department of Medicine and the Co-Director of the Center for AIDS Research at the University of California San Francisco. He is the Chief of the Medical Service at the San Francisco Veterans Affairs Medical Center. He received his medical degree from the University of Minnesota and finished training at University of Utah and the UCSF, where he studied for two years as a research fellow in the virology laboratory of Dr. Jay Levy, later a co-discoverer of HIV. Dr. Volberding's professional activities initially centered at San Francisco General Hospital where he established a model program of AIDS patient care, research, and professional education. His research career began with investigations of HIV related malignancies, especially Kaposi's Sarcoma. His primary research focus, however, shifted to clinical trials of antiretroviral drugs. He has been instrumental in testing many compounds, but is best known for groundbreaking trials establishing standards of care for the use of zidovudine in asymptomatic HIV infection. Dr. Volberding has written many research and review articles. He is the co-editor in chief of the Journal of Acquired Immune Deficiency Syndromes, and is the founder and Chair of the Board of the International AIDS Society- USA and is a past president of the International AIDS Society. He is the Vice President and President –Elect of the HIV Medicine Association of the Infectious Disease Society of America. He is a member of the IOM and has served on several committees addressing the HIV epidemic.

Margaret A. Murray, MPA is the Executive Director of the Association of Health Center Affiliated Health Plans. Her previous experience with healthcare finance includes serving as the Medicaid Director for the New Jersey Department of Human Services, as the Senior Program Examiner for the Office of Management and Budget, as the Senior Associate at the Alpha Center, and as the Health Care Researcher at The Robert Wood Johnson Foundation. She has also held finance positions including Tax Legislative Analyst for Senator Bill Bradley, Revenue Director and Revenue Analyst for the Massachusetts House of Representatives Ways and Means Committee, and Financial Research Assistant for Cambridge Associates. She received her MPA from the Woodrow Wilson School of Public and International Affairs.

William Welton, Dr.PH, MHA is currently a Senior Lecturer and MHA Program Director in the Department of Health Services at the University of Washington, Seattle. From 1994-1998, Dr. Welton served as Founding Dean of the newly developing School of Public Health within MCP Hahnemann University (Philadelphia, PA). In this capacity he led the planning and development of the school, including its innovative and highly successful problem-based learning (PBL) curriculum in public health—the first of its kind in the nation. In 1998, he was awarded the university's prestigious Founder's Award for his leadership role in the school's development. From 1996-2001, he served as Director of the MCP Hahnemann University School of Public Health's Center for Health Management and Policy and as Program Director of the school's part-time MPH Program. Dr. Welton served as a Pew Health Policy Fellow (1994-1999) within the University of Michigan's Department of Health Management and Policy, receiving his Dr.P.H. degree through its Pew Health Policy Program in 1999. From 1972 – 1994 Dr. Welton served as a senior executive manager and governing board member within a variety of academic health systems and managed care organizations. From 1991 – 1994 he also served as Chairman Officer of the American Hospital Association's Health Care Systems Section Governing Council. Dr. Welton's academic and research interests focus on health policy and health services research with an emphasis on health economics, organizational strategy, and strategic and policy-oriented decision analysis.

Martin Shapiro, M.D. practices general internal medicine at the UCLA Medical Center. Dr. Shapiro obtained his undergraduate and medical education at McGill University. Subsequent to that he completed a residency in internal medicine at the Royal Victoria Hospital in Montreal and at UCLA, spent one year engaged in research in the Department of Epidemiology and Health at McGill, and completed a fellowship at UCLA as a Robert Wood Johnson Clinical Scholar. Dr. Shapiro received a Master of Public Health degree in Health Services from UCLA, then a Ph.D. in history also from UCLA, conducting a dissertation on health care services in Portuguese Africa. Dr. Shapiro joined the UCLA faculty in the Division of General Internal Medicine and Health Services Research in 1980 and joined the Department of Health Services in 2000. He is Professor and Chief of the Division of General Internal Medicine and Health Services Research in the Department of Medicine. In 1988, he established the Primary Care Research Fellowship Program at UCLA, which he directs. He is Associate Director of the Clinical Scholars Program. Dr. Shapiro's scholarship has focused on the general theme of assuring that medical care is applied equitably and appropriately to the population and on health services research in the area of HIV disease. He has been the principal investigator on the HIV Costs and Services Utilization Study (HCSUS), a national study of AIDS costs and AIDS patients' access to and quality of care. Dr. Shapiro served on the Institute of Medicine's Committee on the Responsible Conduct of Research. He is President-Elect of the Society of General Internal Medicine.

Janet L. Shikles, M.A., M.S.W. is a health care consultant who works with government agencies, associations and foundations on projects involving health insurance, Medicare, Medicaid, and public health. She also chairs a multi-year project for the Robert Wood Johnson Foundation, which is designed to ensure the health and income of the older workforce. Previously, Ms. Shikles was a Vice President for Health Care Research and Consulting for Abt Associates Inc., a firm specializing in research and evaluation for government agencies and private center health care clients. She also served as the Executive Director of the Commonwealth Fund's Taskforce on the Future of Health Insurance. The goal of this taskforce was to conduct research and evaluations of different approaches to expand insurance coverage to the uninsured. Prior to this she was the Director of Public Policy and Government Relations for the firm Powers, Pyles, Sutter & Verville. Ms. Shikles also served as Assistant Comptroller General in charge of the Health Education and Human Services Division of the US General Accounting Office (GAO) where she was responsible for GAO's work relating to health, education, labor, social security, veterans affairs and welfare programs. She was also the Director of Health Financing and Policy Issues at GAO. Prior to joining GAO, Ms. Shikles was an associate with Booz, Allen and Hamilton. She was also a senior analyst in health research with the Department of Health and Human Services. Ms. Shikles received a bachelor's degree in Government and holds an MA in Political Science from George Washington University and an MSW in Research and Planning from Howard University.

Dr. Beny J. Primm, M.D. has been the Executive Director of the Addiction Research and Treatment Corporation (A.R.T.C.) of Brooklyn, New York since its inception in 1969. Since 1983, Dr. Primm has served as President of the Urban Resource Institute, a non-profit organization that was established to provide supportive social and medical services to critical populations within New York City. In recognition of his world-renowned authority on HIV, addiction, and AIDS, Dr. Primm was appointed to the Presidential Commission of the Human Immunodeficiency Virus Epidemic in 1987. In that capacity, Dr. Primm represented the U.S. at a meeting of the World Health Organization (W.H.O.), Geneva, Switzerland, and at the International Conference for Ministers of Health on AIDS Prevention in London. Dr. Primm has served special committees on drug and alcohol problems for the W.H.O. on several occasions and has represented state and federal governments at special meetings in other European, and African countries, and the Caribbean. He is the chairman of the Board of Directors of the National Minority AIDS Council and is the 1st vice chairman of the National Black Leadership Commission on AIDS. Dr. Primm has been a frequent consultant to the Drug Abuse Policy Office of the White House, beginning with the Nixon Administration, which established the first National Drug Policy Office. In 1989 Dr. Primm as appointed by the Secretary of Health and Human Services to direct the Federal government's Center for Substance Abuse Treatment (CSAT), formerly known as the Office for Treatment Improvement (OTI). Dr. Primm is widely published in treatment of drug abuse and related disorders in peer journals and textbooks. He is the recipient of numerous awards and in November 2000, was granted the Surgeon General's Medallion for U.S. Public Health Service for his lifetime of leadership in mental health and substance abuse treatment in the battle against the AIDS Epidemic. March 2002, he received the Governor's Distinguished Citizen Award from the State of West Virginia. He was also granted the President's Scholar Award from West Virginia State College. Dr. Primm earned his medical degree from the University of Geneva, Geneva, Switzerland.

Andy Schneider, J.D. is Principal of Medicaid Policy, LLC, a consulting firm he founded in Washington D.C. that specializes in issues relating to Medicaid eligibility, benefits, and financing. His former positions include Counsel to the Subcommittee on Health and Environment of the House Energy and Commerce Committee, then chaired by Representative Henry A. Waxman (D-CA); Health Counsel to the Center on Budget Policy and Priorities in Washington, D.C.; and Staff Attorney to the National Health Law Program in Los Angeles, California. Mr. Schneider received his J.D. from the University of Pennsylvania School of Law.

Board Liaison
Joyce Seiko Kobayashi, M.D., is currently an Associate Professor in the Department of Psychiatry at the University of Colorado Health Sciences Center, and Associate Faculty member of the Department of Healthcare Ethics, Humanities and the Law there. Dr. Kobayashi received her undergraduate training at Stanford University, her M.D. from the University of Rochester School of Medicine and completed her psychiatric training at Albert Einstein College of Medicine. She completed a subspecialty fellowship in Consultation/Liaison Psychiatry through Mt. Sinai College of Medicine, and has since specialized in the psychiatric treatment of people with HIV/AIDS. She was an American Psychiatric Association / National Institute of Mental Health (APA/NIMH) Minority Fellow and has served on a number of national Committees and Councils of the APA. During her tenure as Chairperson of the APA Committee of Asian American Psychiatrists, she organized the first International Symposium on Psychiatric Research in Asia. She has served for many years as a member of the National Commission on AIDS of the APA, where she was one of the authors of the needle exchange policy for the Association. She served as a national examiner for the Board of Psychiatry and Neurology. She has been the recipient of several awards, including the Dinkelspiel Award at Stanford, Colorado Woman of the Year in Health and Human Services from the Colorado Asian Pacific Women's Network, and Rocky Mountain Regional AIDS Conference Award for Service to People with AIDS. Dr. Kobayashi has published a variety of articles and chapters on HIV/AIDS, biomedical ethics, women's issues, transcultural psychiatry and has given invited lectures at regional and national AIDS meetings.